Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation

Journal of Clinical Investigation

Volumn 125, Issue 11, 2015, Pages 4171-4185

  Cui, Yue ^a   Franciszkiewicz, Katarzyna ^a   Mburu, Yvonne K ^a   Mondot, Stanislas ^a   Le Bourhis, Lionel ^a   Premel, Virginie ^a   Martin, Emmanuel ^a   Kachaner, Alexandra ^a   Duban, Livine ^a   Ingersoll, Molly A ^b   Rabot, Sylvie ^c   Jaubert, Jean ^b   De Villartay, Jean Pierre ^d   Soudais, Claire ^a   Lantz, Olivier ^a,e,f  

^a PSL RESEARCH UNIVERSITY   (France)

^b INSTITUT PASTEUR   (France)

^c UMR1319 MICALIS   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e Clinical Investigation Center 9201   (France)

^f INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 12 RECEPTOR BETA; INTERLEUKIN 17; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 7 RECEPTOR; PROMYELOCYTIC LEUKEMIA PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; CYTOKINE RECEPTOR; HLA ANTIGEN CLASS 1; KRUPPEL LIKE FACTOR; LYMPHOCYTE ANTIGEN RECEPTOR; LYMPHOKINE; MINOR HISTOCOMPATIBILITY ANTIGEN; MR1 PROTEIN, MOUSE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; ZBTB16 PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BACKCROSSING; BACTERIAL CLEARANCE; BACTERIAL LOAD; BACTERIAL STRAIN; BLADDER; CELL EXPANSION; CELL HOMING; CELL MIGRATION; CELL SURVIVAL; CONGENIC STRAIN; CYTOKINE PRODUCTION; EMBRYO; FEMALE; FLOW CYTOMETRY; GENETIC TRAIT; HUMORAL IMMUNITY; LINKAGE ANALYSIS; LYMPHOCYTIC INFILTRATION; MEMORY T LYMPHOCYTE; MOUSE; MOUSE STRAIN; MUCOSAL ASSOCIATED INVARIANT T CELL; MUS MUSCULUS CASTANEUS; MUS MUSCULUS MUSCULUS; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; THYMOCYTE; THYMUS; URINARY TRACT INFECTION; WILD TYPE; ANIMAL; C57BL MOUSE; CROSS BREEDING; CYTOLOGY; DISEASE MODEL; GENE REARRANGEMENT; GENETICS; GERMFREE ANIMAL; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOID TISSUE; MICROBIOLOGY; MICROFLORA; NEUTROPHIL CHEMOTAXIS; RADIATION CHIMERA; SECRETION (PROCESS); SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC MOUSE;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FEMALE; GENE REARRANGEMENT, ALPHA-CHAIN T-CELL ANTIGEN RECEPTOR; GERM-FREE LIFE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC MEMORY; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOID TISSUE; LYMPHOKINES; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROBIOTA; MINOR HISTOCOMPATIBILITY ANTIGENS; NATURAL KILLER T-CELLS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RADIATION CHIMERA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, CYTOKINE; URINARY TRACT INFECTIONS;

EID: 84946716473     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI82424     Document Type: Article

References (62)

1. Le Bourhis L, Guerri L, Dusseaux M, Martin E, Soudais C, Lantz O. Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol. 2011;32(5):212-218.
2. Le Bourhis L, Mburu YK, Lantz O. MAIT cells, surveyors of a new class of antigen: development and functions. Curr Opin Immunol. 2013;25(2):174-180.
3. Treiner E, et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 2003;422(6928):164-169.
4. Treiner E, Duban L, Moura IC, Hansen T, Gilfil-lan S, Lantz O. Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. Microbes Infect. 2005;7(3):552-559.
5. Gold MC, et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 2010;8(6):e1000407.
6. Le Bourhis L, et al. Antimicrobial activity of muco-sal-associated invariant T cells. Nat Immunol. 2010;11(8):701-708.
7. Georgel P, Radosavljevic M, Macquin C, Bahram S. The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol Immunol. 2011;48(5):769-775.
8. Meierovics A, Yankelevich WJ, Cowley SC. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci USA. 2013;110(33):E3119-E3128.
9. Kjer-Nielsen L, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491(7426):717-723.
10. Corbett AJ, et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature. 2014;509(7500):361-365.
11. Grimaldi D, et al. Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med. 2014;40(2):192-201.
12. Abrahamsson SV, et al. Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. Brain. 2013;136(pt 9):2888-2903.
13. + T cells bear pathogenetic potential in multiple sclerosis. Brain. 2010;134(pt 2):542-554.
14. Magalhaes I, et al. Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J Clin Invest. 2015;125(4):1752-1762.
15. Serriari NE, et al. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol. 2014;176(2):266-274.
16. Cosgrove C, et al. Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood. 2013;121(6):951-961.
17. Leeansyah E, et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood. 2013;121(7):1124-1135.
18. Wong EB, et al. Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection. PLoS One. 2013;8(12):e83474.
19. Fernandez CS, Kelleher AD, Finlayson R, Godfrey DI, Kent SJ. NKT cell depletion in humans during early HIV infection. Immunol Cell Biol. 2014;92(7):578-590.
20. Tilloy F, et al. An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted α/β T cell subpopulation in mammals. J Exp Med. 1999;189(12):1907-1921.
21. Dusseaux M, et al. Human MAIT cells are xeno-biotic resistant, tissue-targeted, CD161hi IL-17 secreting T cells. Blood. 2011;117(4):1250-1259.
22. + T cells. Blood. 2012;119(2):422-433.
23. Huang S, et al. MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution. Proc Natl Acad Sci USA. 2009;106(20):8290-8295.
24. Billerbeck E, et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci USA. 2010;107(7):3006-3011.
25. +IL-18 in a TCR-independent manner. Eur J Immunol. 2014;44(1):195-203.
26. Tang XZ, et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J Immunol. 2013;190(7):3142-3152.
27. + T cells. Int Immunol. 2012;24(10):625-636.
28. Le Bourhis L, et al. MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog. 2013;9(10):e1003681.
29. Kurioka A, et al. MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol. 2015;8(2):429-440.
30. Turtle CJ, et al. Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α semi-invariant T cells. Blood. 2011;118(10):2752-2762.
31. Savage AK, et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity. 2008;29(3):391-403.
32. Martin E, et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol. 2009;7(3):e54.
33. Lepore M, et al. Parallel T-cell cloning and deep sequencing of human MAIT cells reveal stable oligoclonal TCRβ repertoire. Nat Commun. 2014;5:3866.
34. + T cells survives cytotoxic chemotherapy. Immunity. 2009;31(5):834-844.
35. Croxford JL, Miyake S, Huang YY, Shimamura M, Yamamura T. Invariant V(alpha)19i T cells regulate autoimmune inflammation. Nat Immunol. 2006;7(9):987-994.
36. Kawachi I, Maldonado J, Strader C, Gilfillan S. MR1-restricted Vα 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J Immunol. 2006;176(3):1618-1627
37. Shimamura M, Huang YY, Migishima R, Yokoya-ma M, Saitoh T, Yamamura T. Localization of NK1.1(+) invariant Va19 TCR(+) cells in the liver with potential to promptly respond to TCR stimulation. Immunol Lett. 2008;121(1):38-44.
38. Reantragoon R, et al. Antigen-loaded MR1 tet-ramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J Exp Med. 2013;210(11):2305-2320.
39. Chua WJ, Truscott SM, Eickhoff CS, Blazevic A, Hoft DF, Hansen TH. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun. 2012;80(9):3256-3267.
40. Sakala IG, et al. Functional heterogeneity and antimycobacterial effects of mouse mucosal-associated invariant T cells specific for riboflavin metabolites. J Immunol. 2015;195(2) 587-601.
41. Terrence K, Pavlovich CP, Matechak EO, Fowlkes BJ. Premature expression of T cell receptor (TCR) aß suppresses TCRyA gene rearrangement but permits development of yA lineage T cells. J Exp Med. 2000;192(4):537-548.
42. Vera G, et al. Cernunnos deficiency reduces thymocyte life span and alters the T cell repertoire in mice and humans. Mol Cell Biol. 2013; 33(4):701-711.
43. Bosc N, Lefranc MP. The mouse (Mus musculus) T cell receptor a (TRA) and A (TRD) variable genes. Dev Comp Immunol. 2003; 27(6-7):465-497.
44. Guo J, et al. Regulation of the TCRa repertoire by the survival window of CD4(+)CD8(+) thymo-cytes. Nat Immunol. 2002;3(5):469-476.
45. Keane TM, et al. Mouse genomic variation and its effect on phenotypes and gene regulation. Nature. 2011;477(7364):289-294.
46. + T cells. J Exp Med. 2008;205(6):1381-1393.
47. Bautista JL, et al. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol. 2009;10(6):610-617.
48. Rahimpour A, et al. Identification of phenotypi-cally and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers. J Exp Med. 2015;212(7):1095-1108.
49. Soudais C, et al. In vitro and in vivo analysis of the gram-negative bacteria-derived riboflavin precursor derivatives activating mouse MAIT cells. J Immunol. 2015;194(10):4641-4649.
50. Huang S, et al. MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells. J Exp Med. 2008;205(5):1201-1211.
51. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001;69(7):4572-4579.
52. Legoux F, Debeaupuis E, Echasserieau K, De La Salle H, Saulquin X, Bonneville M. Impact of TCR reactivity and HLA phenotype on naive CD8T cell frequency in humans. J Immunol. 2010;184(12):6731-6738.
53. - T cells. J Exp Med. 1994;180(3):1171-1176.
54. Fergusson JR, et al. CD161 defines a transcription-al and functional phenotype across distinct human T cell lineages. Cell Rep. 2014;9(3):1075-1088.
55. Seach N, et al. Double-positive thymocytes select mucosal-associated invariant T cells. J Immunol. 2013;191(12):6002-6009.
56. Leeansyah E, Loh L, Nixon DF, Sandberg JK. Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development. Nat Commun. 2014;5:3143.
57. Biot C, et al. Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med. 2012;4(137):137ra72.
58. Arstila T, et al. Identical T cell clones are located within the mouse gut epithelium and lamina propia and circulate in the thoracic duct lymph. J Exp Med. 2000;191(5):823-834.
59. Magoc T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27(21):2957-2963.
60. Li S, et al. IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling. Nat Commun. 2013;4:2333.
61. Huang S, et al. Evidence for MR1 antigen presentation to mucosal-associated invariant T cells. J Biol Chem. 2005;280(22):21183-21193.
62. Hung CS, Dodson KW, Hultgren SJ. A murine model of urinary tract infection. Nat Protoc. 2009;4(8):1230-1243.